Introduction {#S1}
============

Glutamate (Glu) is the primary excitatory neurotransmitter in the brain which contributes to many physiological processes, including learning and memory ([@B1]). Pathological overstimulation of glutamatergic receptors produces an excessive influx of Ca^+2^ and Na^+^, leading to glutamate-induced neuronal apoptosis and eliciting a marked excitotoxicity ([@B2]). Over-activation of the glutamatergic N-methyl-[d]{.smallcaps}-aspartate (NMDA) receptor in the brain provokes excitotoxic neuronal death which plays a crucial role in many pathological conditions, including ischemic stroke, traumatic brain injury, Alzheimer's disease (AD), Parkinson's disease (PD), and epilepsy ([@B3]). Overactivation of NMDA receptors by Glu is associated with apoptotic cell death *via* release of cytochrome *c* (Cyto-*c*) and induction of the intrinsic apoptotic pathway ([@B4], [@B5]). Cyto-*c* initiates the caspase-dependent apoptotic pathway, which causes proteolytic processing of pro-Caspase-9 and subsequently activation of the downstream effectors caspase-3 (Casp-3), -6, and -7 ([@B6]). Casp-3 causes degradation of nuclear DNA ([@B7]) and formation of peroxynitrite radicals (ONOO^−^), provoking depletion of cellular energy ([@B8]). Moreover, NMDA overactivation was found to increase the production of amyloid-beta (Aβ) protein *via* different potential mechanisms: (1) Ca^2+^-dependent shift from non-amyloidogenic to amyloidogenic processing of the amyloid precursor protein (APP) ([@B9]--[@B11]) and impaired clearance of the Aβ protein from brain and blood ([@B12], [@B13]) and (2) alteration of proteolysis of APP by Casp-3 leading to an increase in Aβ-42 peptide levels ([@B14], [@B15]).

Owing to its antioxidant property, thymoquinone (TQ) was proven to protect different organs against pathological conditions caused by oxidative damage. TQ was also reported as a potent neuroprotective agent against neurodegeneration induced by forebrain ischemia by attenuating oxidative stress ([@B16]). Its antioxidant activity may be attributable to the effect of its reduced form tert-butylhydroquinone, which acts as a hydrogen donating antioxidant that inhibits lipid peroxidation, or to the scavenging effect of multiple reactive oxygen species by TQ and thymohydroquinone, mimicking superoxide dismutase activity ([@B17]). Moreover, TQ can restore the abnormal matrix metalloproteinase and hence decrease reactive oxygen species levels ([@B18]). *In vitro*, TQ had been found to counteract the oxidative stress and membrane potential collapse induced by Aβ-42 aggregation ([@B19]). TQ was found to protect against hepatic apoptosis induced by ischemia reperfusion injury ([@B20], [@B21]). It was also proven to be an effective antineoplastic agent by triggering cancer apoptosis and autophagic cell death ([@B22]), as well as suppressing tumor angiogenesis ([@B23]). TQ also exerted an anti-inflammatory effect against rheumatoid arthritis ([@B24]) and bronchial asthma ([@B25]). Moreover, TQ demonstrated potential anticonvulsant activity against petit-mal epilepsy ([@B26]).

Vitamin E (Vit E) is one of the most powerful natural antioxidants and is essential for protecting the body from free radical damage ([@B27]). It is considered to be a potent protective agent against atherosclerosis, AD, and cancer ([@B28]). Moreover, Vit E was found to protect against apoptotic cell death induced by cinnamaldehyde in PLC/PRF/5 cells ([@B29]), ultra-violet B radiations in chicken embryonic fibroblasts ([@B30]), and haloperidol in hippocampal cell lines ([@B31]).

The aim of the present study was to explore the neuromodulatory effect of different doses of TQ 2.5 and 10 mg/kg against glutamate-induced neuronal damage, by assessing the behavioral changes (spatial memory and cognitive function) and biochemical parameters \[Cyto-*c*, Casp-3, lactate dehydrogenase (LDH), and Aβ levels\] in an animal model using Vit E as a positive control.

Materials and Methods {#S2}
=====================

Material {#S2-1}
--------

### Experimental Animals {#S2-1-1}

Adult male albino rats (weight: 250--300 g; age: \~2 months) were used. The animals were obtained from the animal colony of the National Institute of Research (Cairo, Egypt). The rats were housed in a temperature-controlled room (23--24°C) with a 12-h light:dark cycle and with free access to food and water. They were allowed to acclimatize to the animal house of the German University in Cairo for at least 1 week before initiating the experiments. Animal procedures were performed following the approval of the Ethics Committee of the German University in Cairo in association with the recommendations of the National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No. 85-23, revised 1985). All efforts were made to minimize animal discomfort and suffering.

### Drugs and Chemicals {#S2-1-2}

[l]{.smallcaps}-Glutamic acid monosodium hydrate, TQ, and Vit E were purchased from Sigma-Aldrich Co., USA. Saline 0.9% (NaCl), 70% ethanol, and olive oil were purchased from Adwic (El-Nasr Pharmaceutical Chemicals Co., Egypt), and phosphate buffered saline was purchased from Lonza Ltd., Switzerland.

### Experimental Design {#S2-1-3}

Two control groups were analyzed in the present study. The first group received 1 ml of 0.9% saline i.p. daily for 14 consecutive days and the second group received 1 ml of olive oil i.p. daily for 14 consecutive days. No statistically significant differences were noted in the results among the two control groups, thus, they were pooled into a single control group referred to as the Negative control group in the experimental design and the description of results.

Seventy-two rats weighting were used in the present study and were allocated to five groups, of 12 rats each.

Group I was the Negative control group, while rats in Group II were injected with Glu (2 g/kg, i.p.) once daily for seven consecutive days ([@B1]). Group III was referred to as the VitE/Glu Group in which rats were injected with Vit E (50 mg/kg, i.p.) once daily for seven consecutive days followed by glutamate (2 g/kg, i.p.) for an additional seven consecutive days ([@B32]). In Group IV; the TQ2.5/Glu Group, rats received TQ (2.5 mg/kg, i.p.) once daily for seven consecutive days, followed by glutamate (2 g/kg i.p.) for an additional seven consecutive days ([@B33]). The same protocol was applied in Group 5 (the TQ10/Glu Group) although the dose of TQ was increased to 10 mg/kg ([@B33]).

Methods {#S2-2}
-------

### Neurobehavioral Tests {#S2-2-1}

On the last day of drug treatment, animals were trained for the Y-maze and day 1 of the Morris water maze (MWM). The following day, animals were tested for the Y-maze test and day 2 of MWM. Then, the third and fourth trials of MWM as well as the probe test were conducted on three successive days. Every apparatus was thoroughly washed with 70% ethanol between each use and after every animal in both the training and testing sessions ([@B34]).

#### Y-Maze {#S2-2-1-1}

The Y-maze is used to measure spatial working memory in rodents *via* the spontaneous alternation behavior (SAB) calculation ([@B35]). Spontaneous alternation measures the ability of the animal to alternate its choice of arm entry on subsequent trials based on its memory of pervious arm entries performed ([@B35]), which depends on the natural exploratory behavior of rats for new environments ([@B36]). The maze is a Y-shaped apparatus consisting of three arms, each with the same dimensions, 35-cm long, 25-cm high, and 10-cm wide, and each extending from a central platform, with the angle between each arm equal 120°. The apparatus was placed on the floor of the experimental room. The test was performed for 2 days; the first day was for the purpose of training, during which each rat was positioned in the central platform and allowed to explore the maze freely for 8 min. The same procedure was followed on the second testing day, with the addition of manual recording of each arm entry, scored only when all four limbs of the rat were inside the arm. After each session the maze was cleaned with 70% ethanol to exclude any olfactory cues that might interfere with subsequent testing. An alternation was considered to have occurred if three successive different arms were entered during an overlapping triplet set. The percentage of spontaneous alteration activity (SAB%) was calculated as the "number of consecutive alternations" divided by "the total number of arms entries minus 2" and multiplied by 100 ([@B37]).

#### Morris Water Maze {#S2-2-1-2}

The MWM is one of the most frequently applied *in vivo* neurobehavioral tests in neuroscience ([@B38]). Its advantage over other neurobehavioral tests is its ability to assess and differentiate deficits in memory formation from other types of deficits unrelated to memory including sensory, motor, motivational, and retrieval processes ([@B39]). The test is swimming based model employing distal clues, in which the animal swims from a starting location and navigates to a hidden submerged escape platform. The swimming environment is a large, circular stainless steel pool (150 cm in diameter, 60 cm in height, maintained at a temperature of 25 ± 1°C) half filled with water and divided into four quadrant using two threads positioned perpendicular to each other on the edges of the pool. The platform is positioned 2 cm below the water level in the target quadrant. The platform position remained unchanged throughout the training session, and was rendered invisible by coloring the water using a non-toxic dye. Visual clues, such as colored shapes and stickers, were placed around the pool in plain sight of the animal. The position of the experimenter was constant so as not to disturb the relative location of the water maze with respect to other objects in the laboratory, which serve as prominent visual cues. For four consecutive days, each rat was subjected to two trials where, for each trial, the rat was allowed to search for the fixed platform for 120 s. The gap between the two trials was 10--15 min. On the fifth day, the platform was removed, and each rat was subjected to a probe test during which it was required to swim for 60 s. The time spent by the animal within the probe (target) quadrant was recorded (the quadrant that held the platform during the training days). Time spent in the target quadrant is considered to be an index of memory retrieval ([@B40]--[@B42]).

### Biochemical Assessments {#S2-2-2}

#### Tissue Sampling {#S2-2-2-1}

The rats were sacrificed by cervical dislocation and decapitation, after which, brains were divided into two equal hemispheres in an ice: salt mixture. Each hemisphere was homogenized with the appropriate buffer, according to the assay kits described below.

#### Detection of Cyto-*c* Gene Expression in Brain Tissue {#S2-2-2-2}

Briefly, total RNA was extracted using the Qiagen tissue extraction kit (Qiagen, USA) from the rat brain tissue samples. RNA concentration was obtained by spectrophotometry (Dual wavelength spectrophotometer, Beckman, USA) and was reverse transcribed to cDNA with a high capacity cDNA reverse transcription kit (Fermentas, USA). The qPCR assay was carried out in which amplification and analysis of the converted cDNA were processed employing an Applied Biosystem with software version 3.1. The qPCR assay was optimized by adjusting the annealing temperature such that the sample, together with the primer sets and SYBR Green I, were able to bind. A typical qPCR run includes roughly 40 cycles. The Ct of a sample is defined as the number of PCR cycles necessary for the fluorescent signal produced by SYBR Green to cross above a threshold in the linear part of the amplification curve and it is employed in the analysis step. Relative quantification (RQ), using GAPDH gene expression as an endogenous control, was performed for all samples tested. The RQ was calculated using the 2-DCCT (2^−ΔΔCt^) method ([@B43]).

#### Determination of Casp-3 Levels in Brain Tissue {#S2-2-2-3}

Caspase 3 levels in the brain samples were assayed using Casp-3 ELISA kit (Cusabio, China). This assay measures the amount of sample by sandwiching it between two antibodies one of which is pre-coated to the microtiter plate and the other of which acts as a detector antibody ([@B44]). Antibodies specific for Casp-3 were precoated onto a microplate. Standards and samples are pipetted into the wells and any Casp-3 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for Casp-3 is then added to the wells. After washing, avidin conjugated horseradish peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Casp-3 bound in the initial step. The color development is stopped and the intensity of the color is measured. Casp-3 levels in the brain were expressed as nanograms/milliliter and calculated from a constructed standard curve using known concentrations of Casp-3.

#### Determination of LDH in Brain Tissue {#S2-2-2-4}

Lactate dehydrogenase levels in the brain samples were assayed using an LDH ELISA kit (Stanbio Lab., USA). The microtiter plate provided in this kit was precoated with an antibody specific to LDH. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated polyclonal antibody preparation specific for LDH and avidin conjugated to HRP is added to each microplate well and incubated. Then, a TMB (3,3′,5,5′ tetramethyl-benzidine) substrate solution is added to each well. Only those wells that contain LDH, biotin-conjugated antibody and enzyme-conjugated avidin will exhibit a change in color. The enzyme--substrate reaction is terminated by the addition of a sulfuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 ± 2 nm. LDH levels in the brain were expressed as units/liter and calculated from a constructed standard curve using known concentrations of LDH.

#### Determination of Amyloid-Beta in Brain Tissue {#S2-2-2-5}

Aβ1--42 levels in the brain samples were assayed using an Aβ-42 ELISA kit (MyBiosource, USA). The assay measures the amount of sample by sandwiching it between two antibodies one of which is precoated to the microtiter plate and the other of which acts as a detector antibody ([@B44]). The microtiter plate provided in this kit was precoated with an antibody specific to Aβ1--42. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for Aβ1--42 and avidin conjugated to HRP is added to each microplate well and incubated. Then, a TMB substrate solution is added to each well. Only those wells that contain Aβ1--42, biotin-conjugated antibody and enzyme-conjugated avidin will exhibit a change in color. The enzyme--substrate reaction is terminated by addition of a sulfuric acid solution and the color change is measured spectrophotometrically at a wave length of 450 ± 2 nm. Brain Aβ (1--42) level was expressed as picograms/milliliter and calculated from a constructed standard curve using known concentration of Aβ (1--42).

Statistical Analysis {#S2-3}
--------------------

Data were represented as mean ± SE. Results were analyzed by one-way ANOVA followed by Tukey's Multiple Comparison Test, by the aid of Graph pad prism 5 software. *p*-Value (*p* \< 0.0 5) was considered significant. In the present study \*, @, \#, and X were utilized to denote statistical difference from different groups according to the following scheme: \*: statistically significant from negative control group by *p* value (*p* \< 0.0 5). @: statistically significant from Glu group by *p* value (*p* \< 0.0 5). \#: statistically significant from Vit E/Glu group by *p* value (*p* \< 0.0 5). X: statistically significant from TQ 2.5/Glu group by *p* value (*p* \< 0.0 5).

Results of TQ10/Glu Group were compared to that ofTQ 2.5/Glu, VitE/Glu, and Glu Group. Results of VitE/Glu group were compared to that of Glu group. Results of Glu group were compared to negative control group.

Results {#S3}
=======

Neurobehavioral Tests {#S3-1}
---------------------

### Effect of Different Doses of TQ and Vit E on Spatial Memory in the Y-Maze Test {#S3-1-1}

Glu group showed significant decreased in the SAB% when compared to negative control group by 51.9%. Vit E group showed significant improvement in SAB% when was compared to Glu group by 116%. TQ (2.5 and 10 mg/kg) showed a significant increase in SAB% when compared to Glu group by 109.5 and 112.6%, respectively (Table [1](#T1){ref-type="table"}, Figure [1](#F1){ref-type="fig"}).

###### 

Effects of Glu, Vit E/Glu, TQ 2.5/Glu, and TQ 10/Glu on the spatial memory in the Y-maze test.

  Groups   −ve control     Glu                                             Vit E/Glu                                       TQ 2.5/Glu                                      TQ 10/Glu
  -------- --------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ------------------------------------------------
  SAB%     75.92 ± 8.200   36.53 ± 7.609[\*](#tfn1){ref-type="table-fn"}   78.85 ± 6.99[^@^](#tfn2){ref-type="table-fn"}   76.50 ± 4.15[^@^](#tfn2){ref-type="table-fn"}   77.60 ± 4.885[^@^](#tfn2){ref-type="table-fn"}

*Effect of Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on spatial memory. Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Animals were subjected to the Y-maze test and the SAB% for each rat was recorded for 8 min and the mean SAB% for all rats in each group was calculated. Statistical analysis of mean SAB% were carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. Each value represent the mean value of 12 rats ± SEM*.

*\*Statistically significant from −ve control group (p \< 0.05)*.

*^@^Statistically significant from Glu group (p \< 0.05)*.

![Effect of Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on spatial memory in the Y-maze test. Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Each value represents the mean value of 12 rats ± SEM. Statistics were carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. \*Statistically significant from −ve control group (*p* \< 0.05); ^@^statistically significant from Glu group (*p* \< 0.05); ^\#^statistically significant from Vit E/Glu group (*p* \< 0.05); ^X^statistically significant from TQ 2.5/Glu group (*p* \< 0.05).](fneur-09-00236-g001){#F1}

### Effect of Different Doses of TQ and Vit E on the Mean Escape Latency (MEL) in the MWM Test {#S3-1-2}

The effect of TQ andVit E was estimated on the MEL using MWM after four testing days. MEL on the fourth day was recorded for each mouse. Glu showed significant increase in MEL when compared to the negative control group by 110.12%. Vit E caused a significant reduction in MEL when compared to Glu group by 70.5%. TQ 2.5 and 10 mg/kg showed a significant decrease in MEL when compared to Glu group by 39.4 and 46.3%, respectively (Table [2](#T2){ref-type="table"}, Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}).

###### 

Effect of Glu, Vit E/Glu, TQ 2.5/Glu, and TQ 10/Glu on the mean escape latency (MEL) in Morris water maze (MWM) test.

  Days              −ve control     Glu                                                 Vit E/Glu                                       TQ 2.5/Glu                                       TQ 10/Glu
  ----------------- --------------- --------------------------------------------------- ----------------------------------------------- ------------------------------------------------ ------------------------------------------------
  1st Day MEL (s)   24.46 ± 4.377   62.666670 ± 14.92                                   44.42 ± 18.88                                   61.75 ± 10.20                                    32.58 ± 5.943
  2nd Day MEL (s)   23.54 ± 2.208   63.833330 ± 16.55                                   16.15 ± 3.975                                   17.08 ± 2.336                                    23.42 ± 10.03
  3rd Day MEL (s)   19.96 ± 2.792   47.683330 ± 9.323                                   17.80 ± 4.245                                   12.92 ± 1.67                                     19.5 ± 5.583
  4th Day MEL (s)   11.46 ± 2.208   24.083340 ± 5.352[\*](#tfn3){ref-type="table-fn"}   7.80 ± 1.913[^@^](#tfn4){ref-type="table-fn"}   14.58 ± 3.197[^@^](#tfn4){ref-type="table-fn"}   12.92 ± 3.446[^@^](#tfn4){ref-type="table-fn"}

*Effect of Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on the fourth day MEL in MWM. Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Animals in each group were subjected to MWM test. Animals were subjected to eight training trials, two trials sessions each day for four consecutive days with an inter-trial interval of 5--15 min and the MEL of each animal was recorded for 2 min in each trial. The average MEL of each animal was recorded for the four consecutive days and statistical analysis of the mean MEL of animals in each group were carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. Each value represent the mean value of 12 rats ± SEM. Significant difference between the groups in MEL onthe fourth day was recorded*.

*\*Statistically significant from −ve control group (*p* \< 0.05)*.

*^@^Statistically significant from Glu group (*p* \< 0.05)*.

![Effect of Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on the fourth day mean escape latency in the Morris water maze test. Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Each value represents the mean value of 12 rats ± SEM. Statistics carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. \*Statistically significant from −ve control group (*p* \< 0.05); ^@^statistically significant from Glu group (*p* \< 0.05); ^\#^statistically significant from Vit E/Glu group (*p* \< 0.05); ^X^statistically significant from TQ 2.5/Glu group (*p* \< 0.05).](fneur-09-00236-g002){#F2}

![Effect of Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on mean escape latency in the Morris water maze test. Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Each value represents the mean value of 12 rats ± SEM. Statistics were carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. \*Statistically significant from −ve control group (*p* \< 0.05); ^@^statistically significant from Glu group (*p* \< 0.05); ^\#^statistically significant from Vit E/Glu group (*p* \< 0.05); ^X^statistically significant from TQ 2.5/Glu group (*p* \< 0.05).](fneur-09-00236-g003){#F3}

### Effect of Different Doses of TQ and Vit E on the Probe Test in the MWM Test {#S3-1-3}

The time spent in the target quadrant of the MWM was evaluated by the probe test. Glu group showed a significant decrease in the time spent in the target quadrant when compared to the negative control group by 64%. Vit E group significantly increased the time spent in target quadrant when compared to Glu group by 120.5%. TQ (2.5 and 10 mg/kg) showed a significant increase in the time spent in the target quadrant when compared to Glu group by 114.7 and 117.6%, respectively (Table [3](#T3){ref-type="table"}, Figure [4](#F4){ref-type="fig"}).

###### 

Effect of Glu, Vit E/Glu, TQ 2.5/Glu, and TQ 10/Glu on the probe test in Morris water maze (MWM).

  Groups                                       −ve control      Glu                                             Vit E/Glu                                        TQ 2.5/Glu                                       TQ 10/Glu
  -------------------------------------------- ---------------- ----------------------------------------------- ------------------------------------------------ ------------------------------------------------ -----------------------------------------------
  Mean time spent in the target quadrant (s)   23.75 ± 0.9320   8.500 ± 1.118[\*](#tfn5){ref-type="table-fn"}   18.75 ± 1.726[^@^](#tfn6){ref-type="table-fn"}   18.25 ± 1.078[^@^](#tfn6){ref-type="table-fn"}   18.5 ±1.4232[^@^](#tfn6){ref-type="table-fn"}

*Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Animals in each group were subjected to MWM test. Animals were subjected to probe test and time spent in the target quadrant of each rat was recorded for 60-s period on the fifth day of MWM test. The mean time spent in the target quadrant of all rats in each group was calculated and expressed in seconds. Statistical analysis of mean time spent in target quadrant were carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5*.

*\*Statistically significant from −ve control group (*p* \< 0.05)*.

*^@^Statistically significant from Glu group (*p* \< 0.05)*.

![Effect of Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on the probe test in Morris water maze. Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Each value represents the mean value of 12 rats ± SEM. Statistics were carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. \*Statistically significant from −ve control group (*p* \< 0.05); ^@^statistically significant from Glu group (*p* \< 0.05); ^\#^statistically significant from Vit E/Glu group (*p* \< 0.05); ^X^statistically significant from TQ 2.5/Glu group (*p* \< 0.05).](fneur-09-00236-g004){#F4}

Biochemical Parameters {#S3-2}
----------------------

### Effect of Different Doses of TQ and Vit E on the Cyto-*c* Gene Expression in Brain Tissue {#S3-2-1}

Glu group showed a significant increase in the expression of Cyto-*c* gene, when compared to negative control by 837.01%. Vit E group significantly reduced the expression of Cyto-*c* gene, when compared to Glu group by 71.35%. TQ (2.5 and 10 mg/kg) produced a significant decrease in the expression of Cyto-*c* gene when compared to Glu group by 44.08 and 75.18%, respectively. TQ (10 mg/kg) reduced significantly the expression of Cyto-*c* gene when compared to Vit E group by 14.98%; moreover, it showed a significant decrease when compared to TQ (2.5 mg/kg) by 55.64% (Table [4](#T4){ref-type="table"}, Figure [5](#F5){ref-type="fig"}).

###### 

Effect of Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on Cyto-*c* gene expression.

  Groups                     −ve control     Chi                                            Vit E/Glu                                       TQ 2.5/Glu                                      TQ 10/Glu
  -------------------------- --------------- ---------------------------------------------- ----------------------------------------------- ----------------------------------------------- -----------------------------------------------------------------------------------
  Cyto-*c* gene expression   1.032 ± 0.014   9.67 ± 0.895[\*](#tfn7){ref-type="table-fn"}   2.77 ± 0.148[^@^](#tfn8){ref-type="table-fn"}   5.407 ± 0.98[^@^](#tfn8){ref-type="table-fn"}   2.40 ± 0.264[^X^](#tfn9){ref-type="table-fn"}^,^[^@^](#tfn8){ref-type="table-fn"}

*Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Animals in each group were subjected to the neurobehavioral tests. Once they were scarified, their brains were retrieved and homogenized in its suitable buffer and used in RT-PCR assay*.

*Statistical analysis of mean Cyto-*c* gene expression (RQ) were performed using one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison tests, by graph pad prism 5. Each value represents the mean value of 12 rats ± SEM*.

*\*Statistically significant from −ve control group (*p* \< 0.05)*.

*^@^Statistically significant from Glu group (*p* \< 0.05)*.

*^X^Statistically significant from TQ 2.5/Glu group (*p* \< 0.05)*.

![Effect of Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on Cyto-C gene expression. Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Each value represents the mean value of 12 rats ± SEM. Statistics were carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. \*statistically significant from −ve control group (*p* \< 0.05); ^@^statistically significant from Glu group (*p* \< 0.05); ^\#^statistically significant from Vit E/Glu group (*p* \< 0.05); ^X^statistically significant from TQ 2.5/Glu group (*p* \< 0.05).](fneur-09-00236-g005){#F5}

### Effect of Different Doses of TQ and Vit E on the Casp-3 Levels in Brain Tissue {#S3-2-2}

The Glu group showed a significant increase in the levels of Casp-3 when compared to negative control group by 378%. Vit E group showed a significant decrease in the level of Casp-3 when compared to Glu group by 51.51%. TQ (2.5 and 10 mg/kg) produced a significant decrease in the level of Casp-3 when compared to Glu Group by 62.74 and 85.17%, respectively. TQ (2.5 mg/kg group) reduced the level of Casp-3, compared to Vit E group by 23.14%. TQ (10 mg/kg) group showed a significant decrease in the level of Casp-3 when compared to Vit E and TQ 2.5/kg groups by 69.44 and 60.22%, respectively (Table [5](#T5){ref-type="table"}, Figure [6](#F6){ref-type="fig"}).

###### 

Effects of Glu, Vit E/Glu, TQ 2.5/Glu, and TQ 10/Glu on Casp-3 level.

  Group                                −ve control     Glu                                              Vit E/Glu                                          TQ 2.5/Glu                                         TQ 10/Glu
  ------------------------------------ --------------- ------------------------------------------------ -------------------------------------------------- -------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------
  Concentration of Caspase-3 (ng/ml)   7.833 ± 1.218   37.43 ± 2.260[\*](#tfn10){ref-type="table-fn"}   18.15 ± 0.7610[^@^](#tfn11){ref-type="table-fn"}   13.95 ± 0.4288[^@^](#tfn11){ref-type="table-fn"}   5.550 ± 0.2742[^@^](#tfn11){ref-type="table-fn"}^,^[^\#^](#tfn12){ref-type="table-fn"}^,^[^X^](#tfn13){ref-type="table-fn"}

*Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Animals in each group were subjected to the neurobehavioral tests before being sacrificed. The brains were isolated and homogenized as 10% homogenate in 0.1 M PBS then centrifuged, and supernatants were used in the Casp-3 ELISA kit. Statistical analyses of mean Casp-3 level were performed using ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. Each value represent the mean value of 12 rats ± SEM*.

*\*Statistically significant from −ve control group (*p* \< 0.05)*.

*^@^Statistically significant from Glu group (*p* \< 0.05)*.

*^\#^Statistically significant from Vit E/Glu group (*p* \< 0.05)*.

*^X^Statistically significant from TQ 2.5/Glu group (*p* \< 0.05)*.

![Effect of −ve control, Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on Casp-3 levels. Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Each value represents the mean value of 12 rats ± SEM. Statistics were carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. \*statistically significant from −ve control group (*p* \< 0.05); ^@^statistically significant from Glu group (*p* \< 0.05); ^\#^statistically significant from Vit E/Glu group (*p* \< 0.05); ^X^statistically significant from TQ 2.5/Glu group (*p* \< 0.05).](fneur-09-00236-g006){#F6}

### Effect of Different Doses of TQ and Vit E on the LDH Levels in Brain Tissue {#S3-2-3}

Glu group showed significant increase in the level of LDH when was compared to −ve control by 453.04%. Vit E group showed significant decrease in the level of LDH when compared to Glu group by 55.5%. TQ 2.5 and 10 mg/kg groups showed a significant reduction in the level of LDH when compared to Glu group by 64.40 and 83.40%, respectively. TQ 2.5 mg/kg group showed decrease in LDH level when compared to Vit E group by 19.91%. TQ (10 mg/kg) significantly reduced the LDH level than Vit E and TQ 2.5 mg/kg groups by 62.64 and 53.42%, respectively (Table [6](#T6){ref-type="table"}, Figure [7](#F7){ref-type="fig"}).

###### 

Effect of −ve control, Glu, Vit E/Glu, TQ 2.5/Glu, and TQ 10/Glu on lactate dehydrogenase (LDH) level.

  Groups                    −ve control     Glu                                              Vit E/Glu                                          TQ 2.5/Glu                                         TQ 10/Glu
  ------------------------- --------------- ------------------------------------------------ -------------------------------------------------- -------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------
  Mean level of LDH (U/l)   8.088 ± 1.593   44.73 ± 3.418[\*](#tfn14){ref-type="table-fn"}   19.89 ± 0.8119[^@^](#tfn15){ref-type="table-fn"}   1S.93 ± 0.4335[^@^](#tfn15){ref-type="table-fn"}   7.423 ± 0.3897[^@^](#tfn15){ref-type="table-fn"}^,^[^\#^](#tfn16){ref-type="table-fn"}^,^[^X^](#tfn17){ref-type="table-fn"}

*Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Animals were subjected to the neurobehavioral tests before being sacrificed. The brains were isolated and homogenized as 10% homogenate in 0.1 M PBS then centrifuged, and supernatants were used in the LDH ELISA kit. Statistical analyses of mean LDH level were performed using ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. Each value represents the mean value of 12 rats ± SEM*.

*\*Statistically significant from −ve control group (*p* \< 0.05)*.

*^@^Statistically significant from Glu group (*p* \< 0.05)*.

*^\#^Statistically significant from Vit E/Glu group (*p* \< 0.05)*.

*^X^Statistically significant from TQ 2.5/Glu group (*p* \< 0.05)*.

![Effect of Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on lactate dehydrogenase levels. Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Each value represents the mean value of 12 rats ± SEM. Statistics were carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. \*Statistically significant from −ve control group (*p* \< 0.05); ^@^statistically significant from Glu group (*p* \< 0.05); ^\#^statistically significant from Vit E/Glu group (*p* \< 0.05); ^X^statistically significant from TQ 2.5/Glu group (*p* \< 0.05).](fneur-09-00236-g007){#F7}

### Effect of Different Doses of TQ and Vit E on the Aβ-42 Levels in Brain Tissue {#S3-2-4}

Glu produced a significant increase in the level of Aβ-42 protein when compared to negative control group by 743.33%. Vit E significantly reduced the Aβ1--42 level when compared to Glu group by 60.21%. TQ (2.5 and 10 mg/kg) showed a significant decrease in the Aβ-42 levels when compared to Glu group by 59.60 and 70.04%, respectively (Table [7](#T7){ref-type="table"}, Figure [8](#F8){ref-type="fig"}).

###### 

Effect of Glu, Vit E/Glu, TQ 2.5/Glu, and TQ 10/Glu on the Aβ-42 levels.

  Groups        −ve control     Glu                                              Vit E/Glu                                         TQ 2.5/Glu                                        TQ 10/Glu
  ------------- --------------- ------------------------------------------------ ------------------------------------------------- ------------------------------------------------- -------------------------------------------------
  Aβ-42 pg/ml   1.500 ± 0.155   12.65 ± 0.312[\*](#tfn18){ref-type="table-fn"}   5.033 ± 0.644[^@^](#tfn19){ref-type="table-fn"}   5.107 ± 0.150[^@^](#tfn19){ref-type="table-fn"}   3.793 ± 0.622[^@^](#tfn19){ref-type="table-fn"}

*Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Animals in each group were subjected to the neurobehavioral tests before being sacrificed. The brains were isolated and homogenized as 10% homogenate in 0.1 M PBS then centrifuged, and supernatants were used in the Aβ-42 ELISA kit. Statistical analyses of mean Aβ-42 level were performed using ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. Each value represents the mean value of 12 rats ± SEM*.

*\*Statistically significant from −ve control group (*p* \< 0.05)*.

*^@^Statistically significant from Glu group (*p* \< 0.05)*.

![Effect of −ve control, Glu, Vit E/Glu, TQ2.5/Glu, and TQ10/Glu on Aβ(1--42) levels. Glu was injected i.p. as a single dose for 7 days. TQ and Vit E were injected as a single dose for 7 days. Each value represents the mean value of 12 rats ± SEM. Statistics were carried out by one-way ANOVA followed by Tukey's multiple comparison tests, by graph pad prism 5. \*Statistically significant from −ve control group (*p* \< 0.05); ^@^statistically significant from Glu group (*p* \< 0.05); ^\#^statistically significant from Vit E/Glu group (*p* \< 0.05); ^X^statistically significant from TQ 2.5/Glu group (*p* \< 0.05).](fneur-09-00236-g008){#F8}

Discussion {#S4}
==========

Overactivation of NMDA receptors by Glu induces neuronal apoptosis through excitotoxicity and contributes to many neurological disorders ([@B45]). Importantly, overactivation of NMDA receptors by glutamate also leads to an increase in the level of Aβ1--42, by shifting the APP processing toward the amyloidogenic pathway, resulting in subsequent cognitive dysfunction ([@B10], [@B46]).

In the current study, administration of glutamate produced a significant alteration in spatial memory, as measured by the Y-maze test. This coincides with previous studies whereby Glu-excitotoxicity induced by several agents caused alteration in the SAB%, compared to control groups, in the Y-maze test ([@B47]--[@B49]). Previously, it was shown that bilateral intracerebroventricular administration of Aβ-35 caused impairment in the SAB% and contributed to the neurotoxicity of Aβ through increasing glutamatergic neurotransmission ([@B49]). Moreover, it was observed that olfactory bulbectomy in rodents led to deficits in behavioral and cognitive deficits through glutamate-mediated excitotoxicity manifested by impairment in the SAB% ([@B50]). Furthermore, NMDA receptor overactivation during ischemia in mice contributed to apoptotic cell death in neuronal cells leading to behavioral impairment, also manifested by a decrease in SAB% in the Y-maze test ([@B51]). The MWM is a common test used to assess cognitive and behavioral impairment induced by the administration of monosodium glutamate, which serves as a traumatic brain injury model. Glutamate administration caused spatial reference memory deficits, spatial discrimination deficits and cognitive dysfunction, as shown by an increase in MEL and a decrease in time spent in the target quadrant; these deficits can be attributed to hippocampal cell death induced by excitotoxicity ([@B52]--[@B56]). Consistent with these findings, the current study confirmed that Glu administration for seven consecutive days in the Glu group caused impairment in the spatial memory function which was evidenced by a decrease in MEL and also in the time spent in target quadrant. These findings could be attributed to the increase in the apoptotic cell death markers (Cyto-*c*, Casp-3, and LDH) observed in the present study. This coincides with previous studies showing that either acute or repeated administration of Glu induced the intrinsic pathway of apoptotic cell death through the release of Cyto-*c* and induction of caspase-dependent cell death evidenced by an increase in Cyto-*c* and Casp-3 levels ([@B57]--[@B59]). It was reported the main role of Glu-excitotoxicity in spatial memory impairment induction is through apoptotic cell death, which was confirmed by the increase in caspase activity and demonstrated by the MWM test ([@B60]). Taken together, these studies support the view suggested by the current study that the Glu-excitotoxicity contribution to spatial memory impairment occurs mainly through apoptotic neuronal cell death as a downstream mechanism, which was also suggested by the observed increase in the levels of LDH.

In the current study, Glu administration in the Glu group resulted in an increase in Aβ 1--42 concentration. The mechanism by which excitotoxicity increased Aβ production was previously reported by a study which showed that excitotoxicity following acute brain injury caused an increase in the amyloidogenic processing of APP toward the production of the Aβ protein ([@B14]). This finding is in agreement with a previous report revealing that NMDA receptor activation after acute brain injury may significantly contribute to the development of amyloid plaques ([@B10]). Moreover, a recent study showed that monosodium glutamate administration induced an increase in Aβ accumulation in the rat hippocampus and induced neurobehavioral abnormalities demonstrated by a decrease in SAB% ([@B61]), which coincides with the findings in the present study suggesting a role for the Aβ accumulation in inducing the neurobehavioral deficits observed in rats. In addition, it has been shown that Casp-3 is involved in APP complex proteolysis, causing an increase in Aβ peptide formation ([@B14]). Moreover, Aβ production and accumulation within neuronal cortices consequently was found to induce neuronal apoptotic cell death ([@B62]). Altogether, these findings, together with the findings of the current study, suggest a reciprocal relationship between Aβ production and apoptotic cell death relative to the spatial memory impairment shown here to be a result of Glu administration.

In the current study, administration of both doses of TQ showed a dose-dependent improvement in spatial memory function, as demonstrated by the neurobehavioral tests. Previous studies showed that oral administration of TQ was able to improve spatial memory impairment induced in diabetic rats, as shown by an increase in the SAB% ([@B63]--[@B65]). Recently, it was shown that TQ produced a shortening of the time latency in the MWM ([@B66]) and an increase in the time spent in the target quadrant ([@B67]). Moreover, administration of TQ at a concentration of 10 mg/kg in rats was also able to restore the cognitive impairment induced by status epileptics shown by improvements in the time latency and time spent in the target quadrant in the MWM test ([@B68]). The current study assumed that the improvement of spatial memory observed is attributed to the inhibition of apoptotic cell death which was evidenced by the significant decrease in the apoptotic markers (Cyto-*c* and Casp-3). A previous study showed that administration of TQ to cultured cortical neurons relieved the apoptotic cell death triggered in fetal alcohol syndrome by increasing the expression of Bcl-2, leading to inhibition of Cyto-*c* release and suppressing the activity of the apoptotic caspases, including Casp-3 ([@B20]). In addition, TQ protected against apoptotic cell death following ischemia reperfusion injury in hepatic cells owing to its antioxidant property, reducing NF-κB and Bcl-2 expression, which was reflected by a decrease in the apoptotic cell markers ([@B21]). Moreover, oral administration of TQ attenuated apoptosis of the hippocampus following chronic toluene exposure in rats *via* its antioxidant property, as evidenced by suppression of the activity of Casp-3 ([@B69]). Furthermore, the antiapoptotic property of TQ in *Nigella sativa* contributed to the modulation of neuronal cell death in pentylenetetrazol-induced kindling which occurs in part due to NMDA receptor activation ([@B70]). These findings further support the assumption proposed by the current study, that the maintenance of spatial memory by TQ, demonstrated by the improved SAB%, MEL and time spent in the target quadrant, can be attributed to its antiapoptotic activity, evidenced by the significant decrease in the apoptotic cell markers and the maintenance of cell viability reflected by the decrease in LDH levels. Regarding Aβ, both doses of TQ (5 and 10 mg/kg) reduced Aβ-42 levels. As discussed above, because of the contribution of apoptotic cell death to the increase in Aβ-42 production ([@B14]), the antiapoptotic activity of TQ may contribute to the observed decrease in Aβ-levels. Nanoemulsion of TQ was found to reduce Aβ-42 levels through modulating the processing of APP, decreasing β-secretase and γ-secretase levels and increasing the degradation of Aβ-42 ([@B71]). In addition, a previous study showed that TQ reduced Aβ aggregation as a result of its properties as an antioxidant and antiapoptotic agent ([@B72]). In agreement with these findings, the present study showed that administration of TQ decreased Aβ levels, which could be due to several different mechanisms: (1) the antiapoptotic properties of TQ, (2) shifting APP processing from the amyloidogenic to the non-amyloidogenic pathway, and (3) increasing the clearance of Aβ. Thus, the current study could be extended by evaluating the effect of TQ on the levels of β- and γ-secretase.

In conclusion, TQ treatment caused a decrease in the level of Cyto-*c*, Casp-3, LDH, and Aβ-42 in brain homogenates, thus proving to be a good choice for restoring memory and cognitive deficits induced by Glu-excitotoxicity, as reflected by improvements in SAB%, MEL, and time spent in the target quadrant. We attribute these results to the ability of TQ to counteract the apoptotic cell death and increased Aβ-42 production-induced by Gluowing to its antiapoptotic properties. As a result, TQ reduced cognitive impairment induced by Glu administration and thus it is a promising therapeutic approach against many neurodegenerative diseases that are induced by Glu-excitotoxicity.
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